Syschem (India) Limited (BOM:531173)

India · Delayed Price · Currency is INR

30.86

+0.09 (0.29%)

At close: Sep 11, 2026

Market Cap	1.65B -29.5%
Revenue (ttm)	6.54B +59.1%
Net Income	75.88M +280.0%
EPS	1.28 +169.1%
Shares Out	53.62M
PE Ratio	24.02
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,217
Open	30.77
Previous Close	30.77
Day's Range	30.00 - 31.59
52-Week Range	29.29 - 61.00
Beta	-0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About Syschem (India)

Syschem (India) Limited engages in the production and sale of active pharmaceuticals ingredients (API), intermediates, and bulk drugs in India. Its APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, and cefadroxil. The company also engages in the distillation of specialist solvents, such as methonel, acetonitrile, ethyl acetate, and THF; and contract manufacturing services. Syschem (India) Limited was incorporated in 1993 and is based in Chandiga... [Read more]

Industry Industrial Organic Chemicals

Founded 1993

Employees 115

Stock Exchange Bombay Stock Exchange

Ticker Symbol 531173

Full Company Profile

Financial Performance

In fiscal year 2026, Syschem (India)'s revenue was 6.55 billion, an increase of 69.49% compared to the previous year's 3.86 billion. Earnings were 109.29 million, an increase of 2275.35%.

Financial Statements